Related Experiment Video
Updated: Jun 16, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
[Surgery for diabetes type 2?].
Markus K Müller1, A Nocito, M Schiesser
1Klinik für Viszeral- und Transplantationschirurgie, Universitätsspital Zürich, Zürich. markus.k.mueller@usz.ch
Praxis
|February 19, 2010
Summary
Bariatric surgery significantly improves type 2 diabetes in morbidly obese patients. Metabolic surgery now targets improving glucose metabolism for patients with lower BMIs, showing promise for surgical diabetes management.
Area of Science:
- Endocrinology and Metabolism
- Surgical Science
Context:
- Type 2 diabetes mellitus (T2DM) is a growing public health concern.
- Obesity is a primary risk factor for T2DM development.
- Bariatric surgery has demonstrated efficacy in resolving obesity-related comorbidities, including T2DM.
Purpose:
- To review the impact of bariatric surgery on T2DM in morbidly obese patients.
- To introduce the emerging field of metabolic surgery for T2DM management in non-morbidly obese individuals.
- To highlight the growing interest in surgical interventions for T2DM.
Summary:
- Bariatric surgery leads to T2DM remission or improvement in over 75% of morbidly obese patients (BMI >35).
- Metabolic surgery aims to enhance glucose metabolism, expanding surgical options to patients with BMI <35.
- Observational studies indicate positive outcomes for surgical management of T2DM.
Impact:
- Surgical interventions offer a potential solution for T2DM management beyond traditional therapies.
- Metabolic surgery represents a paradigm shift, broadening the scope of surgical treatment for diabetes.
- Further research into metabolic surgery may lead to novel therapeutic strategies for T2DM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...